PER 1.41% 7.0¢ percheron therapeutics limited

Ann: ANP Updates on US Regulatory Plans for ATL1102 in DMD, page-106

  1. 38 Posts.
    lightbulb Created with Sketch. 3
    Do we know what is required to address the partial hold? Just a revised study protocol will do? It does not seem much but also begs the question why it has not been done already. I am considering a top up.
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.